18F-FDG-PET/CT in malignant mesothelioma

Chiara Fuccio, Elena Giulia Spinapolice, Alice Ferretti, Paolo Castellucci, Maria Cristina Marzola, Giuseppe Trifirò, Domenico Rubello

Research output: Contribution to journalArticle

Abstract

It is well known the useful role of 18F-FDG-PET/CT for differential diagnosis between benign and malignant disease, for staging, for monitoring response and for prognosis regarding mesothelioma. Recently, literature was enriched with new interesting studies regarding the potential applications of 18F-FDG-PET/CT in this field. The purpose of this review is to evaluate articles published on line (PubMed) from January 2011 until October 2012 in order to obtain an overview of recent progress of molecular imaging in malignant mesothelioma. The main topics concern the use of 18F-FDG-PET/CT in radiation therapy planning, monitoring of treatment (surgery/chemotherapy) response and prognosis assessment.

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalBiomedicine and Pharmacotherapy
Volume67
Issue number6
DOIs
Publication statusPublished - Jul 2013

Keywords

  • F-FDG-PET/CT
  • Malignant mesothelioma
  • Prognosis
  • Radiation therapy planning
  • Treatment response

ASJC Scopus subject areas

  • Pharmacology
  • Medicine(all)

Fingerprint Dive into the research topics of '18F-FDG-PET/CT in malignant mesothelioma'. Together they form a unique fingerprint.

  • Cite this

    Fuccio, C., Spinapolice, E. G., Ferretti, A., Castellucci, P., Marzola, M. C., Trifirò, G., & Rubello, D. (2013). 18F-FDG-PET/CT in malignant mesothelioma. Biomedicine and Pharmacotherapy, 67(6), 539-542. https://doi.org/10.1016/j.biopha.2013.01.008